TXGNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
10x Genomics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$69.89+0.03 (+0.04%)
Close on Oct 19, 2026
- Market cap
- $9.08B
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
98.7%
129M of 130M shares
Institutional holders
391
100 new, 33 sold out
Net institutional buying
4M
In Q2 2026
Insider trades, 12 months
0 buys · 50 sales
Net sold $16.88M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 8,496,636 | 7.60% | 13G (passive) amendment | Jun 30, 2025 |
| Vanguard Portfolio Management | 6,981,683 | 5.93% | 13G (passive) | Mar 31, 2026 |
| Catherine D. Wood | 6,272,998 | 5.22% | 13G (passive) amendment | Sep 30, 2026 |
| Vanguard Capital Management | 6,166,597 | 5.24% | 13G (passive) | Mar 31, 2026 |
| Nikko Asset Management Americas, Inc. | 6,009,653 | 5.40% | 13G (passive) | Jun 30, 2025 |
| Millennium Group Management LLC | 5,533,618 | 5.10% | 13G (passive) | Apr 1, 2025 |
| FMR LLC | 18,543,562 | 15.60% | 13G (passive) amendment | Feb 27, 2026 |
| T. Rowe Price Associates, Inc. | 14,044,020 | 11.70% | 13G (passive) | Aug 31, 2026 |
| Abigail P. Johnson | 12,696,254 | 10.80% | 13G (passive) amendment | Dec 31, 2025 |
| ARK Investment Management LLC | 10,003,058 | 8.56% | 13G (passive) amendment | Jun 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of TXG | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| FMR LLC | 17,629,266 | 13.53% | $675.91M | −111,706 | 0.03% |
| BlackRock, Inc. | 10,804,070 | 8.29% | $414.23M | +724,157 | 0.01% |
| ARK Investment Management LLC | 10,003,057 | 7.68% | $383.52M | −1,714,260 | 2.49% |
| Vanguard Portfolio Management LLC | 6,982,492 | 5.36% | $267.71M | +69,556 | 0.01% |
| Quantinno Capital Management LP | 5,469,698 | 4.20% | $209.71M | +57,937 | 0.25% |
| Vanguard Capital Management LLC | 5,082,594 | 3.90% | $194.87M | −186,992 | 0.00% |
| Price T Rowe Associates Inc /Md/ | 4,539,007 | 3.48% | $174.03K | +4,375,792 | 0.02% |
| Sumitomo Mitsui Trust Holdings, Inc. | 4,194,627 | 3.22% | $160.82M | −915,587 | 0.09% |
| Nikko Asset Management Americas, Inc. | 4,192,517 | 3.22% | $160.74M | −911,661 | 2.07% |
| Morgan Stanley | 3,351,911 | 2.57% | $128.51M | +695,558 | 0.01% |
| Goldman Sachs Group Inc | 3,148,859 | 2.42% | $120.73M | −822,941 | 0.01% |
| Geode Capital Management, LLC | 3,082,790 | 2.37% | $118.22M | +178,562 | 0.01% |
| State Street Corp | 2,801,437 | 2.15% | $107.41M | +212,642 | 0.00% |
| Citadel Advisors LLC | 2,779,213 | 2.13% | $106.56M | +2,035,479 | 0.01% |
| Dimensional Fund Advisors LP | 2,225,284 | 1.71% | $85.31M | +182,334 | 0.02% |
| Aqr Capital Management LLC | 2,026,464 | 1.56% | $74.70M | −511,792 | 0.03% |
| Jacobs Levy Equity Management, Inc | 2,019,883 | 1.55% | $77.44M | −263,541 | 0.28% |
| Point72 Asset Management, L.P. | 1,852,776 | 1.42% | $71.04M | New | 0.08% |
| Capital World Investors | 1,493,031 | 1.15% | $57.24M | +40,731 | 0.01% |
| T. Rowe Price Investment Management, Inc. | 1,266,954 | 0.97% | $48.58K | −12,428 | 0.03% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 391 | 129M | 98.7% | 100 / 99 | 140 / 33 | 20M | 16M |
| Q1 2026 | 331 | 125M | 96.1% | 57 / 115 | 103 / 42 | 30M | 16M |
| Q4 2025 | 322 | 124M | 95.3% | 64 / 108 | 98 / 58 | 18M | 18M |
| Q3 2025 | 318 | 124M | 95.2% | 67 / 99 | 90 / 42 | 22M | 21M |
| Q2 2025 | 297 | 123M | 94.3% | 74 / 112 | 74 / 50 | 32M | 23M |
| Q1 2025 | 274 | 114M | 87.7% | 48 / 109 | 75 / 45 | 26M | 16M |
| Q4 2024 | 273 | 105M | 80.4% | 62 / 89 | 92 / 49 | 18M | 16M |
| Q3 2024 | 266 | 105M | 80.4% | 58 / 103 | 73 / 49 | 22M | 16M |
| Q2 2024 | 261 | 105M | 81.0% | 36 / 112 | 78 / 62 | 20M | 27M |
| Q1 2024 | 290 | 114M | 87.4% | 60 / 114 | 76 / 42 | 24M | 12M |
| Q4 2023 | 275 | 102M | 78.3% | 61 / 98 | 80 / 37 | 17M | 5M |
| Q3 2023 | 256 | 91M | 70.1% | 33 / 81 | 101 / 49 | 10M | 9M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of TXG | Value | % of fund | As of |
|---|---|---|---|---|---|
| ARK Innovation ETF | 3,887,549 | 2.98% | $183.76M | 3.30% | Jul 31, 2026 |
| Vanguard Total Stock Market Index Fund | 3,528,683 | 2.71% | $135.29M | 0.01% | Jun 30, 2026 |
| ARK Genomic Revolution ETF | 3,094,931 | 2.38% | $146.30M | 9.39% | Jul 31, 2026 |
| iShares Russell 2000 ETF | 3,031,869 | 2.33% | $116.24M | 0.14% | Jun 30, 2026 |
| Vanguard Small-Cap Index Fund | 2,548,523 | 1.96% | $97.71M | 0.05% | Jun 30, 2026 |
| Select Medical Technology and Devices Portfolio | 2,065,224 | 1.59% | $58.46M | 1.96% | May 31, 2026 |
| Strategic Advisers Fidelity U.S. Total Stock Fund | 1,735,975 | 1.33% | $49.14M | 0.02% | May 31, 2026 |
| Select Health Care Portfolio | 1,600,000 | 1.23% | $45.29M | 0.78% | May 31, 2026 |
| Vanguard Small-Cap Growth Index Fund | 1,467,202 | 1.13% | $56.25M | 0.12% | Jun 30, 2026 |
| T. Rowe Price New Horizons Fund, Inc. | 1,458,300 | 1.12% | $55.91M | 0.38% | Jun 30, 2026 |
| SMALLCAP World Fund Inc | 1,452,300 | 1.11% | $55.68M | 0.06% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 1,341,063 | 1.03% | $51.42M | 0.05% | Jun 30, 2026 |
| VIP Mid Cap Portfolio | 1,321,800 | 1.01% | $50.68M | 0.53% | Jun 30, 2026 |
| T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund | 1,321,693 | 1.01% | $50.67M | 0.52% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 1,303,727 | 1.00% | $61.63M | 0.18% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Serge Saxonov | Chief Executive Officer, Director | 4,153,758 | 3.19% | Sep 24, 2026 |
| Benjamin J. Hindson | See Remarks, Director | 3,621,682 | 2.78% | Aug 26, 2026 |
| Adam Taich | Chief Financial Officer | 330,098 | 0.25% | Sep 11, 2026 |
| Shehnaaz Suliman | Director | 23,792 | 0.02% | Sep 24, 2026 |
| John R. Stuelpnagel | Director | 785,725 | 0.60% | Sep 8, 2026 |
| Sarah A. Teichmann | Director | 28,058 | 0.02% | Aug 17, 2026 |
| Kimberly J. Popovits | Director | 37,445 | 0.03% | Jun 8, 2026 |
| Alan Mateo | Director | 85,877 | 0.07% | Jun 8, 2026 |
| Sridhar Kosaraju | Director | 68,278 | 0.05% | Jun 8, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Shehnaaz Suliman Director | Sep 22, 2026 | Sale(10b5-1 plan) | −1,222 | $82.28 | $100.55K | 23,792 |
| Shehnaaz Suliman Director | Sep 22, 2026 | Sale(10b5-1 plan) | −614 | $79.51 | $48.82K | 28,609 |
| Shehnaaz Suliman Director | Sep 22, 2026 | Sale(10b5-1 plan) | −292 | $78.20 | $22.83K | 29,223 |
| Shehnaaz Suliman Director | Sep 22, 2026 | Sale(10b5-1 plan) | −2,270 | $81.67 | $185.39K | 25,014 |
| Shehnaaz Suliman Director | Sep 22, 2026 | Sale(10b5-1 plan) | −1,325 | $80.82 | $107.09K | 27,284 |
| Serge Saxonov Chief Executive Officer, Director | Sep 22, 2026 | Sale(10b5-1 plan) | −2,800 | $82.37 | $230.64K | 1,050,249 |
| Serge Saxonov Chief Executive Officer, Director | Sep 22, 2026 | Sale(10b5-1 plan) | −2,000 | $79.62 | $159.24K | 1,072,249 |
| Serge Saxonov Chief Executive Officer, Director | Sep 22, 2026 | Sale(10b5-1 plan) | −9,300 | $80.90 | $752.37K | 1,062,949 |
| Serge Saxonov Chief Executive Officer, Director | Sep 22, 2026 | Sale(10b5-1 plan) | −9,900 | $81.83 | $810.12K | 1,053,049 |
| Serge Saxonov Chief Executive Officer, Director | Sep 22, 2026 | Sale(10b5-1 plan) | −1,000 | $78.23 | $78.23K | 1,074,249 |
| Adam Taich Chief Financial Officer | Sep 9, 2026 | Sale(10b5-1 plan) | −31,428 | $64.31 | $2.02M | 330,098 |
| Adam Taich Chief Financial Officer | Sep 9, 2026 | Sale(10b5-1 plan) | −13,754 | $65.26 | $897.59K | 316,344 |
| Adam Taich Chief Financial Officer | Sep 9, 2026 | Sale(10b5-1 plan) | −1,206 | $63.68 | $76.80K | 361,526 |
| John R. Stuelpnagel Director | Sep 3, 2026 | Sale | −6,174 | $62.61 | $386.55K | 328,436 |
| John R. Stuelpnagel Director | Sep 3, 2026 | Sale | −7,012 | $60.66 | $425.35K | 341,424 |
| John R. Stuelpnagel Director | Sep 3, 2026 | Sale | −6,814 | $62.11 | $423.22K | 334,610 |
| Serge Saxonov Chief Executive Officer, Director | Sep 1, 2026 | Gift | −100 | – | – | 1,075,249 |
| Serge Saxonov Chief Executive Officer, Director | Aug 26, 2026 | Sale(10b5-1 plan) | −492 | $64.75 | $31.86K | 1,075,349 |
| Serge Saxonov Chief Executive Officer, Director | Aug 26, 2026 | Sale(10b5-1 plan) | −6,494 | $63.98 | $415.49K | 1,075,841 |
| Serge Saxonov Chief Executive Officer, Director | Aug 26, 2026 | Sale(10b5-1 plan) | −3,500 | $63.02 | $220.57K | 1,082,335 |
| Adam Taich Chief Financial Officer | Aug 24, 2026 | Sale | −17,166 | $63.02 | $1.08M | 362,732 |
| Serge Saxonov Chief Executive Officer, Director | Aug 24, 2026 | Sale | −18,545 | $63.02 | $1.17M | 1,085,835 |
| Benjamin J. Hindson See Remarks, Director | Aug 24, 2026 | Sale | −13,818 | $63.02 | $870.81K | 488,182 |
| Shehnaaz Suliman Director | Aug 24, 2026 | Sale(10b5-1 plan) | −1,646 | $63.97 | $105.29K | 29,515 |
| Shehnaaz Suliman Director | Aug 24, 2026 | Sale(10b5-1 plan) | −561 | $62.73 | $35.19K | 31,161 |
| Serge Saxonov Chief Executive Officer, Director | Aug 20, 2026 | Gift | −4,000 | – | – | 1,104,380 |
| Sarah A. Teichmann Director | Aug 14, 2026 | Sale(10b5-1 plan) | −2,273 | $57.15 | $129.90K | 28,058 |
| Sarah A. Teichmann Director | Aug 13, 2026 | Sale(10b5-1 plan) | −5,278 | $57.29 | $302.38K | 30,331 |
| John R. Stuelpnagel Director | Aug 11, 2026 | Sale | −17,000 | $57.58 | $978.86K | 351,436 |
| John R. Stuelpnagel Director | Aug 11, 2026 | Sale | −3,000 | $58.73 | $176.19K | 348,436 |
| Serge Saxonov Chief Executive Officer, Director | Jun 22, 2026 | Sale(10b5-1 plan) | −9,991 | $34.28 | $342.49K | 1,119,862 |
| Serge Saxonov Chief Executive Officer, Director | Jun 22, 2026 | Sale(10b5-1 plan) | −9,821 | $35.32 | $346.88K | 1,110,041 |
| Serge Saxonov Chief Executive Officer, Director | Jun 22, 2026 | Sale(10b5-1 plan) | −1,661 | $36.16 | $60.06K | 1,108,380 |
| Serge Saxonov Chief Executive Officer, Director | Jun 22, 2026 | Sale(10b5-1 plan) | −8,527 | $33.29 | $283.86K | 1,129,853 |
| Shehnaaz Suliman Director | Jun 16, 2026 | Sale(10b5-1 plan) | −364 | $33.27 | $12.11K | 31,722 |
| Shehnaaz Suliman Director | Jun 16, 2026 | Sale(10b5-1 plan) | −5,359 | $32.59 | $174.65K | 32,086 |
| Shehnaaz Suliman Director | Jun 4, 2026 | Award | +8,829 | – | – | 37,445 |
| John R. Stuelpnagel Director | Jun 4, 2026 | Award | +8,829 | – | – | 368,436 |
| Sarah A. Teichmann Director | Jun 4, 2026 | Award | +8,829 | – | – | 35,609 |
| Kimberly J. Popovits Director | Jun 4, 2026 | Award | +8,829 | – | – | 37,445 |
| Sridhar Kosaraju Director | Jun 4, 2026 | Award | +8,829 | – | – | 65,278 |
| Alan Mateo Director | Jun 4, 2026 | Award | +8,829 | – | – | 85,877 |
| Serge Saxonov Chief Executive Officer, Director | May 26, 2026 | Sale(10b5-1 plan) | −10,718 | $24.71 | $264.84K | 1,138,380 |
| Benjamin J. Hindson See Remarks, Director | May 22, 2026 | Sale | −11,595 | $24.44 | $283.38K | 502,000 |
| Serge Saxonov Chief Executive Officer, Director | May 22, 2026 | Sale(10b5-1 plan) | −18,175 | $24.44 | $444.20K | 1,149,098 |
| Adam Taich Chief Financial Officer | May 22, 2026 | Sale | −15,098 | $24.44 | $369.00K | 379,898 |
| Serge Saxonov Chief Executive Officer, Director | Apr 14, 2026 | Sale(10b5-1 plan) | −5,000 | $24.56 | $122.80K | 1,167,273 |
| Serge Saxonov Chief Executive Officer, Director | Mar 24, 2026 | Sale(10b5-1 plan) | −5,000 | $19.52 | $97.60K | 1,172,273 |
| Serge Saxonov Chief Executive Officer, Director | Mar 23, 2026 | Sale(10b5-1 plan) | −10,000 | $19.13 | $191.30K | 1,177,273 |
| Serge Saxonov Chief Executive Officer, Director | Mar 3, 2026 | Gift | −2,750 | – | – | 1,200,917 |
| Serge Saxonov Chief Executive Officer, Director | Mar 2, 2026 | Sale(10b5-1 plan) | −1,860 | $23.18 | $43.11K | 1,203,667 |
| Serge Saxonov Chief Executive Officer, Director | Mar 2, 2026 | Sale(10b5-1 plan) | −14,292 | $22.67 | $324.00K | 1,205,527 |
| Serge Saxonov Chief Executive Officer, Director | Feb 26, 2026 | Award | +157,895 | – | – | 1,219,819 |
| Benjamin J. Hindson See Remarks, Director | Feb 26, 2026 | Award | +88,816 | – | – | 513,595 |
| Adam Taich Chief Financial Officer | Feb 26, 2026 | Award | +106,579 | – | – | 394,996 |
| Sarah A. Teichmann Director | Feb 25, 2026 | Sale(10b5-1 plan) | −7,579 | $19.41 | $147.11K | 26,780 |
| Serge Saxonov Chief Executive Officer, Director | Feb 23, 2026 | Sale | −9,632 | $18.58 | $178.96K | 1,061,924 |
| Benjamin J. Hindson See Remarks, Director | Feb 23, 2026 | Sale | −7,826 | $18.58 | $145.41K | 424,779 |
| Adam Taich Chief Financial Officer | Feb 23, 2026 | Sale | −8,968 | $18.58 | $166.63K | 288,417 |
| Serge Saxonov Chief Executive Officer, Director | Jan 5, 2026 | Option exercise | +50,000 | $1.20 | $60.00K | 1,071,556 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Suliman Shehnaaz Affiliate | Sep 22, 2026 | 5,723 | $452.69K | Sep 22, 2026 | RSU Vesting |
| Taich Adam Officer | Sep 9, 2026 | 46,388 | $3.00M | Sep 9, 2026 | Restricted Stock |
| John R. Stuelpnagel Director | Sep 3, 2026 | 20,000 | $1.24M | Sep 3, 2026 | Granted as founders shares |
| Saxonov Serge Director, CEO | Aug 26, 2026 | 35,486 | $2.21M | Aug 26, 2026 | RSU Vesting |
| Suliman Shehnaaz Affiliate | Aug 24, 2026 | 2,207 | $143.72K | Aug 24, 2026 | RSU Vesting |
| Serge Saxonov Officer, Director | Aug 24, 2026 | 17,948 | $1.17M | Aug 24, 2026 | Restricted Stock Unit Grant |
| Benjamin J. Hindson Officer, Director | Aug 24, 2026 | 13,373 | $870.85K | Aug 24, 2026 | Restricted Stock Unit Grant |
| Adam Taich Officer | Aug 24, 2026 | 16,614 | $1.08M | Aug 24, 2026 | Restricted Stock Unit Grant |
| A. Polonius-Teichmann Sarah Director | Aug 14, 2026 | 2,273 | $129.90K | Aug 14, 2026 | Restricted Stock |
| A. Polonius-Teichmann Sarah Director | Aug 13, 2026 | 5,278 | $302.38K | Aug 13, 2026 | Restricted Stock |
| John R. Stuelpnagel Director | Aug 11, 2026 | 20,000 | $1.16M | Aug 11, 2026 | Granted as founders shares |
| Suliman Shehnaaz Affiliate | Jun 16, 2026 | 5,723 | $184.40K | Jun 16, 2026 | RSU Vesting |
| Saxonov Serge Director, CEO | May 26, 2026 | 40,718 | $964.20K | May 26, 2026 | RSU Vesting |
| Adam Taich Officer | May 22, 2026 | 11,779 | $290.71K | May 22, 2026 | Restricted Stock Unit Grant |
| Benjamin J. Hindson Officer, Director | May 22, 2026 | 9,430 | $232.73K | May 22, 2026 | Restricted Stock Unit Grant |